DataConnect Is Now Available Globally Across Six Major Digital Platforms
1.7.2021 12:48:00 EEST | Business Wire | Press release
DataConnect, the global initiative to enable viewing mixed-brand fleets in a single platform, is now live with an expanded line of six major digital platforms and available to farm operations around the world. Case IH, STEYR and New Holland now join John Deere, CLAAS and the European farm management platform 365FarmNet, which launched the feature late last fall.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210701005365/en/
DataConnect is a collaboration between CNH Industrial, John Deere, CLAAS and 365FarmNet to enable farms to view all their vehicles within a single digital platform of their choice. Illustration: DataConnect brands
Any farm operations using any self-propelled forage harvesters, combines or tractors from the participating brands now can view it all in one participating platform. Previously, viewing such information required managing additional portal for each brand involved.
With this new approach, customers can view five different machinery data parameters from their machine fleet:
- current machine location
- historical machine position
- fuel tank level
- status of the machine in the field
- machine speed
Any farm operator/owner who want to use the option simply needs to provide themselves with the permission to view all equipment in the platform that is most convenient for them. Once connected, the machines of the other manufactures appear automatically in that portal. The vehicles are even displayed with icons in the respective brand colors.
DataConnect works without any additional hardware and software components and ensures secure data handling. The solution will apply to hundreds of thousands of already connected machines.
The addition of CNH Industrial means that users of AFS Connect, the telematics platform of Case IH, MyPLM Connect for New Holland, and S-Tech for STEYR, will have the option for the cloud-to-cloud exchange of data with both John Deere Operations Center and CLAAS TELEMATICS or 365FarmNet portals.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210701005365/en/
Contact information
John Deere Walldorf GmbH & Co. KG, Impexstraße 3, 69190 Walldorf,
Ralf Lenge, phone: +49 171 4161599, e-mail: LengeRalf@JohnDeere.com
365FarmNet Group KGaA mbH & CoKG, Hausvogteiplatz 10, 10117 Berlin,
Yasmin Möhring, phone: +49 151 172 81 869 e-mail: moehring@365farmnet.com
CLAAS KGaA mbH, Mühlenwinkel 1, 33428 Harsewinkel,
Matthias Mumme, phone: +49 5247/12-2288, e-mail: matthias.mumme@claas.com
CNH Industrial, United States
Dan Danford, phone: +1 (262) 321-8856, e-mail: dan.danford@cnhind.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Azafaros Completes Enrollment of Phase 3 (NAVIGATE) Study Evaluating Nizubaglustat for the Treatment of Patients with GM1/GM2 Gangliosidoses23.7.2026 14:00:00 EEST | Press release
Azafaros, a private company building a portfolio of disease-modifying therapeuticsto become a leader in lysosomal storage disorders (LSDs) focused on addressing neurological symptoms, today announced the completion of patient recruitment in its Phase 3 study evaluating nizubaglustat for the treatment of GM1/GM2 gangliosidoses. “Completing enrollment in our Phase 3 GM1/GM2 study is a significant step toward potentially bringing nizubaglustat to patients and families living with these devastating neurodegenerative diseases," said Stefano Portolano, Chief Executive Officer at Azafaros. "We are deeply grateful to the patients, caregivers, investigators and advocacy groups who have made this milestone possible. As we advance the GM1/GM2 study toward data readout and regulatory submission, we continue to enroll in our Phase 3 NPC study and remain focused on our goal of addressing the significant unmet medical needs faced by these rare disease communities." Professor Roberto Giugliani, Princi
Francisco Partners Closes $21 Billion Across Flagship and Agility Funds23.7.2026 14:00:00 EEST | Press release
Francisco Partners (“FP”), a leading global investment firm that specializes in partnering with technology companies, today announced the closing of $21 billion in capital commitments across its Francisco Partners VIII, L.P. flagship fund and Francisco Partners Agility IV, L.P., its middle-market fund. FP exceeded its initial targets of $14.0 billion and $3.5 billion, respectively. This milestone builds on Francisco Partners' longstanding track record of performance, underscored by its distinction as the only firm to rank among the top three performers in each of the past six HEC-Dow Jones Large Buyout Performance Rankings.* “In our business, long-term success is created through a series of relationships built on years of trust and collaboration," said Dipanjan (“DJ”) Deb, Co-Founder and CEO of Francisco Partners. "We want to thank our investors for their support, our management teams for their dedication and performance, our friends and partners throughout the technology ecosystem, ou
Taiwanese ensembles showcase erhu and ocarina at Prague Folklore Days23.7.2026 11:21:00 EEST | Press release
The Prague Folklore Days 2026 was held on July 17 and 18 in the heart of Prague, bringing together 56 international arts groups from Germany, Austria, Slovakia, Spain, the Netherlands, and Poland. Four Taiwanese groups took part: Hildebrand Yu’s ocarina band, the Shi-xian Huqin Orchestra, the Taipei Folk Orchestra, and the Four Strings Ensemble. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260722841530/en/ Taiwanese ensembles showcase erhu and ocarina at Prague Folklore Days Led by Huang Chun-sin, the official Taiwan representative band featured a diverse lineup of ocarina, erhu, and dance performers. Their program stood out among the European groups with its distinctive character and vivid stage presence. Hildebrand Yu’s ocarina band captivated audiences with warm, uplifting melodies accompanied by the ocarina and ukulele. Yu also performed “Twilight Waltz,” delivering a heartfelt piece of poetic expression, like sunlight
Taiwan Children’s Choirs Garner Major Awards at Hungarian Choral Competition23.7.2026 10:33:00 EEST | Press release
Competing against 36 leading contenders from 20 countries, four Taiwanese children’s choirs have garnered several major awards and top honors at the 5th Budapest International Choral Celebration, showcasing Taiwan’s cultural diversity and music excellence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260722613876/en/ Puzangalan Children’s Choir and Yo Wu Wei Children’s Chorus join forces with international choral ensembles and orchestras to perform Mozart’s Requiem Mass in D minor, K. 626 at the Béla Bartók National Concert Hall of Müpa Budapest. With its pure, angelic voices and exceptional vocal techniques, Puzangalan Children’s Choir from Pingtung County won the top prize, Laurea Summa Cum Laude, in the Grand Prix Competition’s Youth Choir of Equal Voices, Folklore, and Sacred Music categories. In the Open Competition, Yo Wu Wei Children’s Chorus claimed three gold prizes in the categories of Youth Choir of Equal Voices
Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management23.7.2026 10:00:00 EEST | Press release
Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that Evotec (NASDAQ: EVO; Frankfurt Prime Standard: EVT), the global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its top global markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260722261092/en/ Global drug discovery leader partners with Navan to drive operational excellence and eliminate manual expense reporting A life science company that is pioneering the future of drug discovery and development, Evotec had historically managed T&E independently across different countries, meaning employees were dealing with a patchwork of different tools and manual offline processes. As part of its focus on operational excellence, Evotec is further streamlining these processes through one unified, easy-to-use platform that supports consistency, transpar
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom